
mrsa
Sensing COVID-19 In Just 30 Minutes
A test designed by scientists from South Korea can detect SARS-CoV-2 and other harmful microorganisms in about 30 minutes.

Nano-Sensor For Personalized Antibiotic Treatments
The rapid measurement of blood antibiotic levels would allow doctors to tailor the dosage to each individual, according to a study.
MicuRx Expands Clinical Trial Program For Oral Antibiotic MRX-I
MicuRx Pharmaceuticals has initiated a global clinical development program for its lead compound MRX-I.
China’s Zongyi Group Invests In US-Based ContraFect Corporation
The Zongyi Group of China has invested US$8.6 million into US-based ContraFect Corporation as part of a US$9.5 million financing.
Shanghai MengKe Pharma To Develop MRX-I Antibiotic For Chinese Market
MicuRx Pharma and Shanghai Zhangjiang Biomedical Industry Venture Capital today announced a joint venture to develop MRX-I for the Chinese market.
Gene May Offer Clues To Asian Superbug Epidemic
Scientists have discovered a rapidly emerging Staphylococcus aureus gene which is establishing methicillin-resistant S. aureus epidemics across Asia.
IBN And IBM Fight Superbugs With Polymeric Nanoparticles
Scientists at A*STAR and IBM Research – Almaden have developed biodegradable polymer nanoparticles that combat drug-resistant superbugs.